196 related articles for article (PubMed ID: 9923515)
21. Effect of antimicrobial agents, especially fosfomycin, on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157:H7.
Yoh M; Frimpong EK; Honda T
FEMS Immunol Med Microbiol; 1997 Sep; 19(1):57-64. PubMed ID: 9322069
[TBL] [Abstract][Full Text] [Related]
22. Serotype, Shiga toxin (Stx) type, and antimicrobial resistance of Stx-producing Escherichia coli isolated from humans in Shizuoka Prefecture, Japan (2003-2007).
Hiroi M; Takahashi N; Harada T; Kawamori F; Iida N; Kanda T; Sugiyama K; Ohashi N; Hara-Kudo Y; Masuda T
Jpn J Infect Dis; 2012; 65(3):198-202. PubMed ID: 22627299
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic-Mediated Modulations of Outer Membrane Vesicles in Enterohemorrhagic Escherichia coli O104:H4 and O157:H7.
Bauwens A; Kunsmann L; Karch H; Mellmann A; Bielaszewska M
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28607018
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of antibiotics used for enterohemorrhagic Escherichia coli O157 enteritis--effect of various antibiotics on extracellular release of verotoxin].
Ito T; Akino E; Hiramatsu K
Kansenshogaku Zasshi; 1997 Feb; 71(2):130-5. PubMed ID: 9077070
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and assessment of globotriose-chitosan conjugate, a novel inhibitor of shiga toxins produced by Escherichia coli.
Li X; Wu P; Cheng S; Lv X
J Med Chem; 2012 Mar; 55(6):2702-10. PubMed ID: 22372889
[TBL] [Abstract][Full Text] [Related]
26. Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7.
Yoh M; Frimpong EK; Voravuthikunchai SP; Honda T
Can J Microbiol; 1999 Sep; 45(9):732-9. PubMed ID: 10526400
[TBL] [Abstract][Full Text] [Related]
27. Occurrence, virulence genes and antibiotic resistance of Escherichia coli O157 isolated from raw bovine, caprine and ovine milk in Greece.
Solomakos N; Govaris A; Angelidis AS; Pournaras S; Burriel AR; Kritas SK; Papageorgiou DK
Food Microbiol; 2009 Dec; 26(8):865-71. PubMed ID: 19835773
[TBL] [Abstract][Full Text] [Related]
28. [Status of emerging drug resistance in Shiga toxin-producing Escherichia coli in Japan during 1996: a minireview].
Yamamoto T; Wakisaka N
Nihon Rinsho; 1998 Oct; 56(10):2718-29. PubMed ID: 9796342
[TBL] [Abstract][Full Text] [Related]
29. Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome.
Cornick NA; Jelacic S; Ciol MA; Tarr PI
J Infect Dis; 2002 Jul; 186(1):57-63. PubMed ID: 12089662
[TBL] [Abstract][Full Text] [Related]
30. [New knowledge of the molecular biology of enterohemorrhagic Escherichia coli (EHEC) O157].
Karch H; Köhler B
Gesundheitswesen; 1999 Oct; 61 Spec No 1():S46-51. PubMed ID: 10593045
[TBL] [Abstract][Full Text] [Related]
31. Subtype-specific suppression of Shiga toxin 2 released from Escherichia coli upon exposure to protein synthesis inhibitors.
Pedersen MG; Hansen C; Riise E; Persson S; Olsen KE
J Clin Microbiol; 2008 Sep; 46(9):2987-91. PubMed ID: 18650349
[TBL] [Abstract][Full Text] [Related]
32. Vitamin K Analogs Influence the Growth and Virulence Potential of Enterohemorrhagic Escherichia coli.
Kijewski A; Witsø IL; Iversen H; Rønning HT; L'Abée-Lund T; Wasteson Y; Lindbäck T; Aspholm M
Appl Environ Microbiol; 2020 Nov; 86(24):. PubMed ID: 32769190
[TBL] [Abstract][Full Text] [Related]
33. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina.
Rivas M; Miliwebsky E; Chinen I; Roldán CD; Balbi L; García B; Fiorilli G; Sosa-Estani S; Kincaid J; Rangel J; Griffin PM;
Foodborne Pathog Dis; 2006; 3(1):88-96. PubMed ID: 16602984
[TBL] [Abstract][Full Text] [Related]
34. Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2.
Donohue-Rolfe A; Kondova I; Oswald S; Hutto D; Tzipori S
J Infect Dis; 2000 May; 181(5):1825-9. PubMed ID: 10823794
[TBL] [Abstract][Full Text] [Related]
35. Is Shiga Toxin-Negative Escherichia coli O157:H7 Enteropathogenic or Enterohemorrhagic Escherichia coli? Comprehensive Molecular Analysis Using Whole-Genome Sequencing.
Ferdous M; Zhou K; Mellmann A; Morabito S; Croughs PD; de Boer RF; Kooistra-Smid AM; Rossen JW; Friedrich AW
J Clin Microbiol; 2015 Nov; 53(11):3530-8. PubMed ID: 26311863
[TBL] [Abstract][Full Text] [Related]
36. [Antimicrobial susceptibility of shiga toxin producing E coli (STEC) strains isolated from human infections and food].
Reyes MS; Durán CT; Prado VJ
Rev Med Chil; 2004 Oct; 132(10):1211-6. PubMed ID: 15631209
[TBL] [Abstract][Full Text] [Related]
37. Sorbitol-fermenting, β-glucuronidase-positive, Shiga toxin-negative Escherichia coli O157:H7 in free-ranging red deer in South-Central Spain.
Díaz S; Vidal D; Herrera-León S; Sánchez S
Foodborne Pathog Dis; 2011 Dec; 8(12):1313-5. PubMed ID: 21819212
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial and antimotility agent use in persons with shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites.
Nelson JM; Griffin PM; Jones TF; Smith KE; Scallan E
Clin Infect Dis; 2011 May; 52(9):1130-2. PubMed ID: 21467017
[TBL] [Abstract][Full Text] [Related]
39. Multiple antibiotic resistances among Shiga toxin producing Escherichia coli O157 in feces of dairy cattle farms in Eastern Cape of South Africa.
Iweriebor BC; Iwu CJ; Obi LC; Nwodo UU; Okoh AI
BMC Microbiol; 2015 Oct; 15():213. PubMed ID: 26475706
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Escherichia coli Isolates from humans, food, and farm and companion animals for presence of Shiga toxin-producing E. coli virulence markers.
Murinda SE; Nguyen LT; Landers TL; Draughon FA; Mathew AG; Hogan JS; Smith KL; Hancock DD; Oliver SP
Foodborne Pathog Dis; 2004; 1(3):178-84. PubMed ID: 15992278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
